Physician profile
Jonathan S Friedstat
NPI 1316056245
$58,616.53
in general payments reported to CMS, 2019-2025
15 companies · $29K in 2025
The $29K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,323 · 2020: $45.64 · 2021: $3,526 · 2022: $1,565 · 2023: $129 · 2024: $19K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $22K · Travel and Lodging: $13K · Consulting Fee: $8,940 · Food and Beverage: $3,367 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $22,020.00 |
| Travel and Lodging | $12,979.67 |
| Consulting Fee | $8,940.00 |
| Food and Beverage | $3,366.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $45,213.41 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Mallinckrodt Enterprises LLC | $5,126.92 | 2019 | |
| Avita Medical Americas, LLC | $3,946.37 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Medline Industries LP | $3,415.02 | 2021 | |
| Integra Lifesciences Corporation | $257.39 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Access Pro Medical, LLC | $219.32 | 2025 | Matriderm |
| Derma Sciences, INC. | $136.09 | 2019 | |
| Smith+Nephew, INC. | $72.56 | 2019-2024 | Renasys Touch, Renasys Go V2 Home |
| Organogenesis INC. | $58.07 | 2023-2024 | Puraply |
| Kci USA, INC. | $50.23 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $35.01 | 2025 | |
| Lifenet Health | $33.48 | 2023 | |
| Solventum Corporation | $26.98 | 2024 | V.A.C. Granufoam, V.A.C.Ulta |
| Urgo Medical North America, LLC | $25.68 | 2024 | Urgoclean Ag |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Friedstat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.